FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

38182007: Galactose (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
64837013 Galactose en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
771757013 Galactose (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2692811000005112 Galactose da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Galactose Is a Carbohydrate metabolism disorder marker true Inferred relationship Some
Galactose Is a Hexose true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Galactose challenge tests Has measured component False Galactose Inferred relationship Some
Galactose renal clearance measurement Has measured component False Galactose Inferred relationship Some
Galactose measurement, urine Has measured component False Galactose Inferred relationship Some
Galactose measurement Has measured component False Galactose Inferred relationship Some
Galactose screening test for galactosaemia Has measured component False Galactose Inferred relationship Some
Galactose challenge tests Component True Galactose Inferred relationship Some 1
Galactose renal clearance measurement Component False Galactose Inferred relationship Some
Galactose measurement, urine Component False Galactose Inferred relationship Some 2
Galactose measurement Component True Galactose Inferred relationship Some 1
Galactose screening test for galactosaemia Component True Galactose Inferred relationship Some 1
galaktosemikropartikler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galactose Inferred relationship Some
galaktosemikropartikler 3 g granulat + vehikel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galactose Inferred relationship Some
galaktosemikropartikler 3996 mg + palminsyre 4 mg pulver og opløsningsmiddel til hætteglas med injektionsvæske, suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galactose Inferred relationship Some
galaktosemikropartikler 2497,5 mg + palminsyre 2,5 mg pulver og opløsningsmiddel til hætteglas med injektionsvæske, suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galactose Inferred relationship Some
Fecal galactose level (procedure) Component False Galactose Inferred relationship Some 2
galaktosemikropartikler 3996 mg + palminsyre 4 mg granulat + diluent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galactose Inferred relationship Some
galaktosemikropartikler 2497,5 mg + palminsyre 2,5 mg granulat + diluent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galactose Inferred relationship Some
Product containing galactose (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Galactose Inferred relationship Some 1
Product containing galactose and palmitic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Galactose Inferred relationship Some 1
Increase or decrease in galactose content of the diet. Direct substance True Galactose Inferred relationship Some 1
Decreased galactose diet (regime/therapy) Direct substance True Galactose Inferred relationship Some 1
Galactose microparticles+palmitic acid 2497.5mg/2.5mg granules The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galactose Inferred relationship Some
Galactose microparticles+palmitic acid 3996mg/4mg granules The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Galactose Inferred relationship Some
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Galactose Inferred relationship Some 1
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Galactose Inferred relationship Some 1
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Galactose Inferred relationship Some 1
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Galactose Inferred relationship Some 1
Product containing galactose and palmitic acid in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Galactose Inferred relationship Some 1
Galactose only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Galactose Inferred relationship Some 1
Galactose and palmitic acid only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Galactose Inferred relationship Some 1
Product containing only galactose and palmitic acid in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Galactose Inferred relationship Some 1
Galactose intake This attribute specifies the resulting output of the process characterized by the observed feature. False Galactose Inferred relationship Some 2
Increase in galactose content of the diet compared to the assessed baseline intake of galactose for the individual. Direct substance True Galactose Inferred relationship Some 1
The known quantity of intake of galactose from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. This attribute specifies the resulting output of the process characterized by the observed feature. False Galactose Inferred relationship Some 5
The approximate quantity of intake of galactose from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. This attribute specifies the resulting output of the process characterized by the observed feature. False Galactose Inferred relationship Some 5
The approximate quantity of intake of galactose from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. This attribute specifies an entity that the process which the property characterizes specifically acts on. False Galactose Inferred relationship Some 5
Galactose intake This attribute specifies an entity that the process which the property characterizes specifically acts on. False Galactose Inferred relationship Some 2
The known quantity of intake of galactose from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. This attribute specifies an entity that the process which the property characterizes specifically acts on. False Galactose Inferred relationship Some 5
Galactose intake This attribute specifies an entity that the process which the property characterizes specifically acts on. True Galactose Inferred relationship Some 1
The approximate quantity of intake of galactose from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. This attribute specifies an entity that the process which the property characterizes specifically acts on. True Galactose Inferred relationship Some 1
The known quantity of intake of galactose from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. This attribute specifies an entity that the process which the property characterizes specifically acts on. True Galactose Inferred relationship Some 1
Fecal galactose level (procedure) Component True Galactose Inferred relationship Some 1
Galactose measurement, urine Component True Galactose Inferred relationship Some 1

This concept is not in any reference sets

Back to Start